Raposas, Jerald L.

HRN: 22-45-32  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CEFTRIAXONE 1G (VIAL)
01/04/2023
01/10/2023
IV
2g
OD
Fracture, Open Complete Displaced Femur,left Sec To Mva
Waiting Final Action 
01/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/04/2023
01/10/2023
IV
600 Mg
Q6H
Fracture, Open Complete Femur, Left Sec To Mva
Waiting Final Action 
01/12/2023
CEFTRIAXONE 1G (VIAL)
01/12/2023
01/14/2023
IV
2g
OD
Fracture, Open, Femur, S/p ORIF
Waiting Final Action 
01/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2023
01/18/2023
IV
600mg
Q6hrs
Fracture Open III B, M/3rd, Femur, Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: